The Phase IIb OPTIONS study, powered and designed specifically to answer this question in humans, found no statistically significant weight loss versus placebo at 24 weeks [9]
Anti-diabetic drugs with beneficial role in the commonly associated co-morbid conditions can offer value addition in therapy
Sayin VI, LeBoeuf SE, Singh SX, Davidson SM, Biancur D, Guzelhan BS, Alvarez SW, Wu WL, Karakousi TR, Zavitsanou AM, Ubriaco J, Muir A, Karagiannis D, Morris PJ, Thomas CJ, Possemato R, Vander Heiden MG, Papagiannakopoulos T
One of its remarkable benefits lies in its capacity to efficiently replenish your cellular glutathione levelsa vital antioxidant in your body